A 2023 study published in the Journal of Clinical Endocrinology and Metabolism found that GLP-1 receptor agonist therapy in women with obesity and insulin resistance produced significant improvements in androgen levels, menstrual regularity, and metabolic markers, with effects most pronounced in women with baseline hyperinsulinemia, underscoring how tightly GLP-1 mechanisms are connected to broader hormonal function in women
Semaglutide, in research terms Semaglutide is the most extensively studied of the three
Wolfe B et al
Slow titration reduces digestive side effects
Larios didnt want to watch his new client lose, gain, lose again, then gain again, but thats how things started
To understand tirzepatide-specific timing, how fast tirzepatide works covers the pharmacokinetic details, and how long it takes for tirzepatide to work addresses onset expectations